Nasim Afsar is a healthcare executive and the former Chief Health Officer of Oracle, the COO of UC Irvine Health, and the Chief Quality Officer of UCLA Health.
This is definitely where humanity is going, and where it will end up. Universally (almost) lists of essential medicines for treating prevalent conditions is an extant stepping stone in this direction. RBCDB studies will be run on thousands of genomes in silico vastly accelerating the availability -- and known limitations -- of new molecules to treat literally thousands of diseases.
I love this concept! One thing I keep thinking about- what could be done to account for difference in resources among geographies- e.g. availability of CT scans, labs, skilled providers performing diagnostics e.g. colonoscopy..
Insightful piece, @DJ. Long time, no speak, btw! While the creation of universal standards of care is, indeed, an ambitious task that I fear is not likely to get traction with the current US administration, there are companies doing amazing “de facto” work in this area. #Avo is one of my favorites. If you haven’t heard of them or seen their tech in action, I encourage you to do so —> https://www.avomd.com. And feel free to hmu for an intro to Yair, Avo’s CEO and a practicing internal medicine MD. He’s amazing and you two would surely hit it off. Best, Travis (formerly of Neuvotion)
This is definitely where humanity is going, and where it will end up. Universally (almost) lists of essential medicines for treating prevalent conditions is an extant stepping stone in this direction. RBCDB studies will be run on thousands of genomes in silico vastly accelerating the availability -- and known limitations -- of new molecules to treat literally thousands of diseases.
I love this concept! One thing I keep thinking about- what could be done to account for difference in resources among geographies- e.g. availability of CT scans, labs, skilled providers performing diagnostics e.g. colonoscopy..
Insightful piece, @DJ. Long time, no speak, btw! While the creation of universal standards of care is, indeed, an ambitious task that I fear is not likely to get traction with the current US administration, there are companies doing amazing “de facto” work in this area. #Avo is one of my favorites. If you haven’t heard of them or seen their tech in action, I encourage you to do so —> https://www.avomd.com. And feel free to hmu for an intro to Yair, Avo’s CEO and a practicing internal medicine MD. He’s amazing and you two would surely hit it off. Best, Travis (formerly of Neuvotion)